Discontinued — last reported Q4 '25
Year-over-year, this metric declined by 100.0%, from $1.20B to $0.00.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
proceeds_from_sale_of_business| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.20B | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | — | — | — | — | -100.0% | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | — | — | — | — | -100.0% |